SENORES

Senores Pharmaceuticals Shareholding Pattern

₹1,390.00+0.10%
Market cap
₹6,401 crore
P/E
50.7
P/B
3.20
ROE
16.4%
Dividend yield
1.20%

As of 30-JUN-2026, promoters held 45.82% of Senores Pharmaceuticals (0.00 pp from 31-MAR-2026), foreign institutional investors 6.62%, domestic institutions 9.77% and the public 37.79%.

Senores Pharmaceuticals shareholding pattern

Percentage of shares held, by quarter, newest first.

Senores Pharmaceuticals shareholding by category (% of equity)
Holder30-JUN-202631-MAR-202631-DEC-202530-SEP-202530-JUN-202531-MAR-2025Change
Promoters45.82%45.82%45.80%45.80%45.78%n/a0.00 pp
Foreign institutions (FII/FPI)6.62%3.64%3.35%4.28%3.67%n/a+2.98 pp
Domestic institutions (DII)9.77%9.61%9.31%8.61%9.51%n/a+0.16 pp
Public37.79%40.93%41.54%41.31%41.04%n/a-3.14 pp

Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.

Senores Pharmaceuticals shareholding pattern — frequently asked questions

What is the promoter holding in Senores Pharmaceuticals?

Promoters held 45.82% of Senores Pharmaceuticals as of 30-JUN-2026, unchanged from 45.82% in 31-MAR-2026.

How much do FIIs hold in Senores Pharmaceuticals?

Foreign institutional investors held 6.62% of Senores Pharmaceuticals as of 30-JUN-2026, a change of +2.98 pp from the previous quarter.

How much do domestic institutions hold in Senores Pharmaceuticals?

Domestic institutional investors, including mutual funds and insurers, held 9.77% of Senores Pharmaceuticals as of 30-JUN-2026 (+0.16 pp from the previous quarter).

Who owns Senores Pharmaceuticals?

As of 30-JUN-2026, Senores Pharmaceuticals' shareholders were promoters (45.82%), foreign institutional investors 6.62%, domestic institutions 9.77% and the public 37.79%, as filed with the stock exchanges.

Same Data For Peers

Trade Senores Pharmaceuticals With ATS

Track SENORES live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.